Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Australian (ASX) Healthcare Sector Analysis

UpdatedNov 11, 2025
DataAggregated Company Financials
Companies127
  • 7D0.2%
  • 3M-17.7%
  • 1Y-22.8%
  • YTD-19.3%

Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by Pro Medicus declining 1.5%. The industry has fallen 23% in the last year. As for the next few years, earnings are expected to grow by 17% per annum.

Sector Valuation and Performance

Has the Australian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 11 Nov 2025AU$222.5bAU$74.6bAU$4.6b32.2x48.4x3x
Thu, 09 Oct 2025AU$240.2bAU$74.6bAU$4.6b30.2x52.5x3.2x
Sat, 06 Sep 2025AU$241.1bAU$74.8bAU$4.6b32.2x52.4x3.2x
Mon, 04 Aug 2025AU$271.9bAU$70.4bAU$4.9b37.6x55.7x3.9x
Wed, 02 Jul 2025AU$255.5bAU$71.7bAU$4.3b26.2x60x3.6x
Fri, 30 May 2025AU$259.5bAU$72.0bAU$4.3b27.2x60.3x3.6x
Sun, 27 Apr 2025AU$246.5bAU$70.7bAU$4.9b27.3x50.4x3.5x
Tue, 25 Mar 2025AU$254.9bAU$71.1bAU$4.9b28.1x51.9x3.6x
Thu, 20 Feb 2025AU$241.1bAU$66.0bAU$3.6b29.6x67.9x3.7x
Sat, 18 Jan 2025AU$244.1bAU$69.0bAU$3.4b26x71.9x3.5x
Mon, 16 Dec 2024AU$242.8bAU$68.3bAU$3.3b26.3x73.4x3.6x
Wed, 13 Nov 2024AU$243.5bAU$67.8bAU$3.2b25.1x76.6x3.6x
Fri, 11 Oct 2024AU$244.3bAU$67.2bAU$3.1b28.4x79.4x3.6x
Sun, 08 Sep 2024AU$240.5bAU$67.0bAU$3.1b26.2x78.4x3.6x
Tue, 06 Aug 2024AU$236.6bAU$63.5bAU$2.7b28.9x86.7x3.7x
Thu, 04 Jul 2024AU$234.0bAU$62.7bAU$2.6b31.9x89.5x3.7x
Sat, 01 Jun 2024AU$224.6bAU$61.0bAU$2.6b28.4x85.2x3.7x
Mon, 29 Apr 2024AU$219.4bAU$61.5bAU$2.7b27.3x82.3x3.6x
Wed, 27 Mar 2024AU$224.5bAU$61.6bAU$2.7b26.7x84.6x3.6x
Fri, 23 Feb 2024AU$223.2bAU$60.7bAU$3.2b27.4x70.5x3.7x
Sun, 21 Jan 2024AU$225.7bAU$60.4bAU$2.8b24.9x79.5x3.7x
Tue, 19 Dec 2023AU$219.6bAU$60.1bAU$2.8b24.8x78x3.7x
Thu, 16 Nov 2023AU$205.0bAU$60.6bAU$2.9b24.5x70.8x3.4x
Sat, 14 Oct 2023AU$194.7bAU$61.5bAU$3.0b24.9x65.5x3.2x
Mon, 11 Sep 2023AU$210.4bAU$61.4bAU$2.9b25.8x72.1x3.4x
Wed, 09 Aug 2023AU$209.9bAU$58.2bAU$3.0b26.2x70.7x3.6x
Fri, 07 Jul 2023AU$213.4bAU$57.9bAU$2.9b29.2x73.3x3.7x
Sun, 04 Jun 2023AU$231.9bAU$57.9bAU$2.9b26.1x79.5x4x
Tue, 02 May 2023AU$231.7bAU$57.3bAU$2.9b29.5x80.1x4x
Thu, 30 Mar 2023AU$219.4bAU$57.2bAU$2.9b27.6x76.5x3.8x
Sat, 25 Feb 2023AU$226.5bAU$57.0bAU$3.1b23.5x71.9x4x
Mon, 23 Jan 2023AU$226.4bAU$55.1bAU$3.9b25.8x57.7x4.1x
Wed, 21 Dec 2022AU$214.6bAU$55.9bAU$4.1b24.8x52.4x3.8x
Fri, 18 Nov 2022AU$222.3bAU$55.5bAU$4.1b25.8x54.9x4x
Price to Earnings Ratio

54.9x


Total Market Cap: AU$222.3bTotal Earnings: AU$4.1bTotal Revenue: AU$55.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Healthcare Sector Price to Earnings3Y Average 70.3x202320242025
Current Industry PE
  • Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 47.9x which is lower than its 3-year average PE of 70.3x.
  • The 3-year average PS ratio of 3.7x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 4.6% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Australian Healthcare sector?

AU Market-0.88%
Healthcare0.18%
Biotech1.18%
Life Sciences0.59%
Healthcare Services0.28%
Medical Equipment-0.78%
Healthtech-1.05%
Pharma-5.87%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 1kx.
    • Analysts are expecting annual earnings growth of 23.0%, which is lower than the prior year's growth of 62.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 56% over the next 5 years.
  • This is better than its past earnings decline of 0.5% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CSL CSLAU$178.912.0%
+AU$1.7b		-37.7%PE18.8x
SIG Sigma HealthcareAU$3.120.6%
+AU$230.0m		n/aPE67.7x
REG Regis HealthcareAU$7.685.2%
+AU$114.9m		17.8%PE47.4x
SHL Sonic HealthcareAU$21.120.9%
+AU$93.9m		-22.4%PE20.3x
AYA ArtryaAU$3.6710.5%
+AU$52.8m		634.0%PS19766.7x

Latest News

TLX
AU$15.32
Telix Pharmaceuticals
7D
-3.1%
1Y
-34.4%
4DX
AU$1.64
4DMedical
7D
2.5%
1Y
227.0%

4DX: Continued Revenue Momentum Will Drive Upside Following Regulatory Milestones

Analysts have revised their price target for 4DMedical to $1.82 per share, maintaining the previous valuation. Cautious adjustments to profit margin forecasts were offset by sustained robust revenue growth expectations.
NAN
AU$4.30
Nanosonics
7D
-4.4%
1Y
31.1%
ONE
AU$0.23
Oneview Healthcare
7D
21.1%
1Y
-28.1%

Investors Don't See Light At End Of Oneview Healthcare PLC's (ASX:ONE) Tunnel

Nov 06
Investors Don't See Light At End Of Oneview Healthcare PLC's (ASX:ONE) Tunnel
NEU
AU$18.67
Neuren Pharmaceuticals
7D
-10.9%
1Y
14.3%
MSB
AU$2.29
Mesoblast
7D
-7.7%
1Y
56.8%
RHC
AU$30.62
Ramsay Health Care
7D
-3.1%
1Y
-20.3%

RHC: Stable Profit Margins And Discount Rate Set To Support Share Strength

Analysts have maintained their fair value estimate for Ramsay Health Care at $37.23 per share. They cite stable growth and profitability projections, even though there has been a slight decrease in the discount rate used in their valuation models.
CSL
AU$178.91
CSL
7D
2.0%
1Y
-37.7%

CSL: Share Price Correction Will Present Opportunity As Vaccine Uncertainty Eases

CSL's analyst price target has been lowered from A$280.61 to A$246.49, reflecting analysts' revised expectations following recent updates about weaker revenue growth, a more cautious profit margin outlook, and continued challenges in key business units. Analyst Commentary Market analysts have offered mixed perspectives on CSL following recent trading updates and management commentary, resulting in shifts in both ratings and price targets.
SHL
AU$21.12
Sonic Healthcare
7D
0.9%
1Y
-22.4%

Sonic Healthcare (ASX:SHL) Seems To Use Debt Quite Sensibly

Nov 02
Sonic Healthcare (ASX:SHL) Seems To Use Debt Quite Sensibly
REG
AU$7.68
Regis Healthcare
7D
5.2%
1Y
17.8%
SIG
AU$3.12
Sigma Healthcare
7D
0.6%
1Y
n/a

A Look At The Intrinsic Value Of Sigma Healthcare Limited (ASX:SIG)

Oct 15
A Look At The Intrinsic Value Of Sigma Healthcare Limited (ASX:SIG)
CU6
AU$4.62
Clarity Pharmaceuticals
7D
-4.1%
1Y
-38.2%
AYA
AU$3.67
Artrya
7D
10.5%
1Y
634.0%
PME
AU$257.75
Pro Medicus
7D
-1.5%
1Y
28.4%

Does Pro Medicus (ASX:PME) Deserve A Spot On Your Watchlist?

Oct 08
Does Pro Medicus (ASX:PME) Deserve A Spot On Your Watchlist?
ACW
AU$0.041
Actinogen Medical
7D
13.9%
1Y
70.8%
LDX
AU$0.18
Lumos Diagnostics Holdings
7D
-25.0%
1Y
480.6%